DCM
MRTX

Delpha Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Delpha Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,294
Closed -$24K – 1332
2017
Q4 		$24K Buy
+1,294
New +$24K 0.03% 692